These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 10794091)

  • 1. Residual risk of transfusion transmitted viral infections among seronegative donors: application of the incidence/window period model.
    Kleinman S
    Dev Biol (Basel); 2000; 102():61-5. PubMed ID: 10794091
    [No Abstract]   [Full Text] [Related]  

  • 2. Residual risk of transfusion-transmitted human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in Italy.
    Gonzalez M; Règine V; Piccinini V; Vulcano F; Giampaolo A; Hassan HJ
    Transfusion; 2005 Oct; 45(10):1670-5. PubMed ID: 16181219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus.
    Seed CR; Kiely P; Keller AJ
    Intern Med J; 2005 Oct; 35(10):592-8. PubMed ID: 16207258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current incidence and estimated residual risk of transfusion-transmitted infections in donations made to Canadian Blood Services.
    O'Brien SF; Yi QL; Fan W; Scalia V; Kleinman SH; Vamvakas EC
    Transfusion; 2007 Feb; 47(2):316-25. PubMed ID: 17302779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current incidence and residual risk of HIV, HBV and HCV at Canadian Blood Services.
    O'Brien SF; Yi QL; Fan W; Scalia V; Fearon MA; Allain JP
    Vox Sang; 2012 Jul; 103(1):83-6. PubMed ID: 22289147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.
    Vermeulen M; Lelie N; Sykes W; Crookes R; Swanevelder J; Gaggia L; Le Roux M; Kuun E; Gulube S; Reddy R
    Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The incidence/window period model and its use to assess the risk of transfusion-transmitted human immunodeficiency virus and hepatitis C virus infection.
    Kleinman S; Busch MP; Korelitz JJ; Schreiber GB
    Transfus Med Rev; 1997 Jul; 11(3):155-72. PubMed ID: 9243769
    [No Abstract]   [Full Text] [Related]  

  • 8. [Blood-transfusion in Vietnam].
    Nakada S
    Nihon Koshu Eisei Zasshi; 1994 Jan; 41(1):95-100. PubMed ID: 7906568
    [No Abstract]   [Full Text] [Related]  

  • 9. The risks of transfusion-transmitted infection: direct estimation and mathematical modelling.
    Kleinman SH; Busch MP
    Baillieres Best Pract Res Clin Haematol; 2000 Dec; 13(4):631-49. PubMed ID: 11102281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Residual risk of infections transmitted by blood component transfusion].
    Couroucé AM
    Rev Epidemiol Sante Publique; 1994; 42(5):463-6. PubMed ID: 7973006
    [No Abstract]   [Full Text] [Related]  

  • 11. Does prevalence of transfusion-transmissible viral infection reflect corresponding incidence in United States blood donors?
    Wang B; Schreiber GB; Glynn SA; Kleinman S; Wright DJ; Murphy EL; Busch MP;
    Transfusion; 2005 Jul; 45(7):1089-96. PubMed ID: 15987352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Refinement of a viral transmission risk model for blood donations in seroconversion window phase screened by nucleic acid testing in different pool sizes and repeat test algorithms.
    Weusten J; Vermeulen M; van Drimmelen H; Lelie N
    Transfusion; 2011 Jan; 51(1):203-15. PubMed ID: 20707858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C virus.
    Li L; Chen PJ; Chen MH; Chak KF; Lin KS; Tsai SJ
    Transfusion; 2008 Jun; 48(6):1198-206. PubMed ID: 18422856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infectious pathogens in volunteer and replacement blood donors in Pakistan: a ten-year experience.
    Sultan F; Mehmood T; Mahmood MT
    Int J Infect Dis; 2007 Sep; 11(5):407-12. PubMed ID: 17331775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infectious markers in blood donors of East Delhi: prevalence and trends.
    Singh B; Kataria SP; Gupta R
    Indian J Pathol Microbiol; 2004 Oct; 47(4):477-9. PubMed ID: 16295370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus.
    Hourfar MK; Jork C; Schottstedt V; Weber-Schehl M; Brixner V; Busch MP; Geusendam G; Gubbe K; Mahnhardt C; Mayr-Wohlfart U; Pichl L; Roth WK; Schmidt M; Seifried E; Wright DJ;
    Transfusion; 2008 Aug; 48(8):1558-66. PubMed ID: 18466173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of replacement blood donors to study the epidemiology of major blood-borne viruses in the general population of Maputo, Mozambique.
    Cunha L; Plouzeau C; Ingrand P; Gudo JP; Ingrand I; Mondlane J; Beauchant M; Agius G
    J Med Virol; 2007 Dec; 79(12):1832-40. PubMed ID: 17935167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transfusion-transmitted viral infections. Retrovirus and Viral Hepatitis Working Groups of the French Society of Blood Transfusion.
    Couroucé AM; Pillonel J
    N Engl J Med; 1996 Nov; 335(21):1609-10. PubMed ID: 8927113
    [No Abstract]   [Full Text] [Related]  

  • 19. [Viral safety of blood and blood products].
    Gürtler L
    Fortschr Med; 1993 Nov; 111(33):526-7. PubMed ID: 8307536
    [No Abstract]   [Full Text] [Related]  

  • 20. Monitoring viral incidence rates: tools for the implementation of European Union regulations.
    Janssen MP; Cator EA; van der Poel CL; Schaasberg WP; Bonsel GJ; van Hout BA
    Vox Sang; 2009 May; 96(4):298-308. PubMed ID: 19228368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.